At CDMO Live 2025, a panel sponsored by Lifecore Biomedical brought together industry quality leaders to discuss how quality management can become a strategic enabler rather than a compliance burden. The panel featured Jackie Klecker (EVP Quality & Development Services,
“Risk is always a function of volatility. And I think everyone agrees that volatility in markets, also in the pharmaceutical industry with regards to tariffs, has actually increased,” explains David Schneider, CEO of Qualifyze, discussing the evolving landscape of supplier
“We invest to meet the needs of the customer. What’s driving these investments are really the customer partnerships that we’re building to make these happen,” explains Arul Ramadurai, Chief Commercial Officer at Axplora. Axplora, a global leader in API small
National Resilience, the contract development and manufacturing organisation (CDMO) that has raised over $2 billion since its 2020 founding, announced Monday it would “wind down” facilities whilst securing $250 million in bridge financing from existing investors. The company’s restructuring involves
At CDMO Live 2025, a panel of digital manufacturing experts explored how pharma companies are transforming external manufacturing operations through digital integration. Sponsored by Aizon. The Digital Divide: Big Pharma vs Mid-Size Players The panellists painted a stark contrast in
ANNOUNCEMENT New regional event series addresses urgent need for strategic collaboration amid industry disruption PharmaSource today announced the launch of External Manufacturing Leaders, an exclusive forum series for senior pharmaceutical professionals navigating external manufacturing strategy. The launch follows CDMO Live
Experience the future of external manufacturing at CDMO Live, Rotterdam.
19-21st May 2026
“Know your supply chain. Make sure you have it well mapped. The biggest thing that we’ve seen coming out of COVID was investments in technology – that’s what’s helping manufacturers respond to the unexpected.” Ryan Kelly, Senior Director of Supply
Prerna Srivastava is a Content Producer at Life Science Networks Can you tell us a little about your background and how you came to join our company? I hold a Master’s in Biotechnology and have a background in the life
“There are not that many European CDMOs with commercial expertise in cell therapy – who understand the regulatory requirements and production challenges when you have to manufacture large quantities on a regular basis. This is why we ended up with
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
